Tom Louwen

As precision medicine, cell and gene therapies, and other advanced therapeutic modalities become more prevalent, supply chains are becoming increasingly complex and patient-centric. At the same time, the industry must navigate geopolitical uncertainty, evolving regulatory requirements and ongoing pressure to improve speed, quality, and cost efficiency. 

The future of pharmaceutical manufacturing will be defined not only by scientific innovation, but by the industry's ability to deliver the right therapy to the right patient at the right time. Building supply chains that are resilient, agile, and digitally connected will be essential to ensuring continuity of supply and accelerating access to life-changing medicines. Achieving this vision demands greater manufacturing flexibility, end-to-end visibility, intelligent use of AI and digital technologies, and closer collaboration across the entire pharmaceutical ecosystem.

In this session we discuss the strategies shaping the next generation of pharmaceutical supply chains and explore how organisations can build resilient operations capable of adapting to an increasingly dynamic global landscape. 

Join this session to: 

• Discover how digital technologies are transforming supply chain planning, manufacturing, and decision-making. 
• Understand practical approaches to increasing manufacturing flexibility without compromising quality or regulatory compliance. 
• Gain insights into effective risk management strategies for today's increasingly complex global manufacturing environment.